6th International Virtual Congress (IVC-2019) And Workshop.  International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Prevalence of malaria among symptomatic outpatient children of Hasiya Bayero Pediatric Hospital, Kano Nigeria

Author Affiliations

  • 1Biology Department, Kano University of Science and Technology, Wudil, P.M.B.3244, Kano Nigeria
  • 2Biology Department, Kano University of Science and Technology, Wudil, P.M.B.3244, Kano Nigeria

Int. Res. J. Medical Sci., Volume 7, Issue (1), Pages 1-6, January,28 (2019)

Abstract

A cross sectional study was carried out to evaluated the incidence of malaria among symptomatic outpatient children of Hasiya Bayero Pediatric Hospital, Kano Nigeria. A total of 150 symptomatic outpatients children randomly participated, were diagnosed for malaria infection and identified the Plasmodium species in the blood samples infected individuals. The result obtained showed 80% (120/150) prevalence of malaria infection among the sampled population. The high positive predictive value 80.4% recorded indicated the quality of the diagnostic test employed (thin films) in the study. While low negative predictive value 20.8% shows that malaria infection is not excluded among the outpatient children. The odd ratio of 1.075 suggested that children presented with fever and other symptoms are more likely to have malaria infection than those presented with fever only. The diagnostic test results and the gender of the children are not related significantly (p>0.05). Male children are less likely to be infected with malaria than the female children (odds ratio=0.599). Also the age categories of the outpatient children are not related with the test results significantly (p>0.05). The age group 1-3 years were more likely to be infected with malaria disease than the age group 4-6 years (odds ratio=2.213). The Clinical presentations are less likely to occur in children infected with P. malariae than those infected with P. falciparum (odds ratio=0.610) and there was no significant relationship (p >0.05) between clinical presentations of the children and the species of Plasmodium in the blood samples of infected individuals. The prevalence of malaria was higher among the participants with more females aged 1-3 years presented with fever and other symptoms having high risk of infection with P. falciparum.

References

  1. Foster S. and Phillips M. (1998)., Economics and its contribution to the fight against malaria., Annals of Tropical Medicine and Parasitology, 92(4), 391-398.
  2. Ogungbamigbe T.O., Ogunro P.S., Elemile P.O., Egbewale B.E., Olowu O.A. and Abiodun O.O. (2005)., Prescription patterns of antimalarial drugs among medical practitioners in Osogbo Metropolis, South-West Nigeria., Trop. Med. Health, 33(4), 201-208.
  3. Molineaux L. (1997)., Malaria and mortality: some epidemiological considerations., Annals of Tropical Medicine & Parasitology, 91(7), 811-825.
  4. Auwaerter P.G. (2006)., Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control?., Expert review of anti-infective therapy, 4(6), 1039-1049.
  5. Mharakurwa S., Rangarira R., Murahwa F.C. and Chandiwana S.K. (1998)., Status of chloroquine efficacy against falciparum malaria in the Mola area of Kariba district, Zimbabwe., Annals of Tropical Medicine & Parasitology, 92(6), 655-661.
  6. Clemente J.C., Govindasamy L., Madabushi A., Fisher S.Z., Moose R.E., Yowell C.A., Hidaka K., Kimura T., Hayashi Y., Kiso Y., Agbandje-Mckenna M., Dame J.B., Dunn B.M. and McKenna R. (2006)., Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor., Acta Crystallographica Section D., 62(3), 246-252. doi:10.1107/S0907444905041260.
  7. Collins W.E. and Jeffery G.M. (2005)., Plasmodium ovale: Parasite and Disease., Clin Microbiol Rev., 18(3), 570-581. doi:10.1128/CMR.18.3.570-581.2005.
  8. WHO (2010)., Global report on antimalarial drug efficacy and drug resistance: 2000-2010., World Health Organization, Geneva, Switzerland, November 2010.
  9. Onyiri N. (2015)., Estimating malaria burden in Nigeria: a geostatistical modelling approach., Geospat Health, 10(2), 306. doi: 10.4081/gh.2015.306.
  10. Oyeyi T.I., Hamidu M.R. and Dakata M.A. (2009)., Slide positivity rate of malaria among patients attending two hospitals in Kano Metropolis., Bayero J. Pure Appl. Sci., 2(2), 194-196.
  11. Taura D. and Oyeyi T. (2009)., Prevalence of malarial parasites in pregnant women attending Sir Muhammad Sunusi Specialist Hospital, Kano, Nigeria., Bayero J. Pure Appl. Sci., 2, 186-188.
  12. Isah M.A., Darma A.I. and Sani I. (2014)., Prevalence of malarial parasites in pregnant women attending Aminu Kano Teaching Hospital, Kano, Nigeria., Asian J. Adv. Basic Sci., 3, 117-121.
  13. Report (2016)., Health reporters, Africa's online health newspaper., avaible at http://www.Healthreporters.info /2016/04/27/kano-records-22000-malaria-deaths-in-2015. Accessed on 2 June, 2017.
  14. White N.J. and Breman J.G. (2008)., Malaria., In Harrisons Principles of Internal Medicine, 17th ed., D Kasper E., Braunwald A.S., Fauci S.L., Hauser D.L., Longo J. L., Jameson Eds, McGraw Hill Co., New York, 280-1294.
  15. RTS S. (2015)., Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial., Lancet., 386, 31-45.
  16. World Health Organization (1991)., Basic laboratory methods in medical parasitology., Reprinted 1997, Printed in England 88/8318-Macmillan/Clays-7000 97/11444-Clays-1000. 40-47 & 83-86
  17. Marc Triola M.D. (2005)., Statdisk software, Addison Wesley, Inc.,
  18. Texasoft (2015)., WINSK SDA 7 software, Window Kwikstat., available at www.Texasoft.com (2015).
  19. Oche A.O. and Aminu M. (2012)., The prevalence of malarial parasitaemia among blood donorsin Ahmadu Bello University Teaching Hospital, Shika, Zaria, Nigeria., Niger J. Med., 21(4), 445-449.
  20. Gajida A.U., Iliyasu Z. and Zoakah A.I. (2010)., Malaria among antenatal client attending primary health care facilities in Kano state, Nigeria., Ann Afr. Med., 9(3), 188-193.
  21. Beare N.A., Lewallen S., Taylor T.E. and Molyneux M.E. (2011)., Redefining cerebral malaria by including malaria retinopathy., Future Microbiology, 6(3), 349-355. doi:10.2217/fmb.11.3.
  22. Sinclair D., Donegan S., Isba R. and Lalloo D.G. (2012)., Artesunate versus quinine for treating severe malaria., Cochrane Database of Systematic Reviews, 6. CD005967.
  23. Stauffer W.M., Cartwright C.P., Olson D.A., Juni B.A., Taylor C.M., Bowers S.H. and Boulware D.R. (2009)., Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice., Clinical Infectious Diseases, 49(6), 908-913.
  24. Redd S.C., Luby S.P., Hightower A.W., Kazembe P.N., Nwanyanwu O., Ziba C. and Wirima J.J. (1996)., Clinical algorithm for treatment of Plasmodium falciparum malaria in children., The Lancet, 347(8996), 223-227. doi:10.1016/S0140-6736(96)90404-3.
  25. Dawaki S., Al-Mekhlafi H.M., Ithoi I., Ibrahim J., Atroosh W.M., Abdulsalam A.M. and Ahmed A. (2016)., Is Nigeria winning the battle against malaria? Prevalence, risk factors and KAP assessment among Hausa communities in Kano State., Malaria journal, 15(1), 351. doi: 10.1186/s12936-016-1394-3.
  26. Temu E.A., Coleman M., Abilio A.P. and Kleinschmidt I. (2012)., High prevalence of malaria in Zambezia, Mozambique: the protective effect of IRS versus increased risk due to pig-keeping and house construction., PloS One, 7, e31409.
  27. Brooker S., Clarke S., Njagi J.K., Polack S., Mugo B., Estambale B. and Cox J. (2004)., Spatial clustering of malaria and associated risk factors during an epidemic in a highland area of western Kenya., Tropical medicine & international health, 9(7), 757-766.
  28. Smith T., Felger I., Tanner M. and Beck H.P. (1999)., Premunition in Plasmodium falciparum infection: insights from then epidemiology of multiple infections., Trans. R Soc. Trop. Med. Hyg., 93 (Suppl. 1), 59-64.
  29. WHO (2015)., Achieving the malaria MDG target: reversing the incidence of malaria 2000-2015., Geneva: World Health Organisation and United Nations Children's Fund.
  30. Loha E. and Lindtjørn B. (2012)., Predictors of Plasmodium falciparum malaria incidence in Chano Mille, South Ethiopia: a longitudinal study., Am. J. Trop. Med. Hyg., 87(3), 450-459.
  31. MDG Region (2015)., Combating the disease, along with HIV/AIDS., United Nation General Assembly.
  32. NIH (2007)., U.S. department of health and human services National Institutes of Health National Institute of Allergy and Infectious Diseases., NIH Publication No. 07-7139, February 2007 www.niaid.nih.gov Accessed on 2 June, 2017.
  33. Bruce M.C., Macheso A., Galinski M.R. and Barnwell J.W. (2006)., Characterization and application of multiple genetic markers for Plasmodium malariae., Parasitology, 134(5), 637-650. doi:10.1017/S003118 2006001958.